Submitted:
17 June 2026
Posted:
18 June 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
3.1. Darwin Prospective Melioidosis Study (DPMS)
3.2. Dry Season Cases
3.3. Environmental Exposure Events During the Dry Season
3.4. Darwin Cases of Melioidosis and Weather Correlation





3.5. Explanations for Dry Season Melioidosis

4. Discussion
4.1. Demographics and Clinical Parameters
4.2. Seasonality and Rainfall
4.3. Environmental Exposures and Infecting Events
4.4. Limitations
4.5. Recommendations and Prevention Strategies
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data availability statement
Acknowledgements
Conflicts of interest
Abbreviations
| B. pseudomallei | Burkholderia pseudomallei |
| DPMS | Darwin Prospective Melioidosis Study. |
| BOM | Australian Bureau of Meteorology. |
| NT | Northern Territory |
| ABS | Australian Bureau of Statistics |
References
- Petras, J.K.; Elrod, M.G.; Ty, M.C.; Dawson, P.; O’Laughlin, K.; Gee, J.E.; Hanson, J.; Boutwell, C.; Ainsworth, G.; Beesley, C.A.; et al. Locally Acquired Melioidosis Linked to Environment — Mississippi, 2020–2023. New England Journal of Medicine 2023, 389, 2355–2362. [CrossRef]
- Currie, B.J.; Kaestli, M.; Meumann, E.M. Global dispersal of Burkholderia pseudomallei and the evolving endemicity of melioidosis in the United States of America. PLOS Neglected Tropical Diseases 2026, 20, e0014217. [CrossRef]
- Gassiep, I.; Armstrong, M.; Norton, R. Human Melioidosis. Clinical Microbiology Reviews 2020, 33, 10.1128/cmr.00006–00019. [CrossRef]
- Meumann, E.M.; Limmathurotsakul, D.; Dunachie, S.J.; Wiersinga, W.J.; Currie, B.J. Burkholderia pseudomallei and melioidosis. Nature Reviews Microbiology 2024, 22, 155–169. [CrossRef]
- Zimmermann, R.E.; Ribolzi, O.; Pierret, A.; Rattanavong, S.; Robinson, M.T.; Newton, P.N.; Davong, V.; Auda, Y.; Zopfi, J.; Dance, D.A.B. Rivers as carriers and potential sentinels for Burkholderia pseudomallei in Laos. Scientific Reports 2018, 8, 8674. [CrossRef]
- Gee, J.E.; Bower, W.A.; Kunkel, A.; Petras, J.; Gettings, J.; Bye, M.; Firestone, M.; Elrod, M.G.; Liu, L.; Blaney, D.D.; et al. Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray. New England Journal of Medicine 2022, 386, 861–868. [CrossRef]
- Mayo, M.; Kaesti, M.; Harrington, G.; Cheng, A.C.; Ward, L.; Karp, D.; Jolly, P.; Godoy, D.; Spratt, B.G.; Currie, B.J. Burkholderia pseudomallei in unchlorinated domestic bore water, Tropical Northern Australia. Emerg Infect Dis 2011, 17, 1283–1285. [CrossRef]
- McRobb, E.; Sarovich Derek, S.; Price Erin, P.; Kaestli, M.; Mayo, M.; Keim, P.; Currie Bart, J. Tracing Melioidosis Back to the Source: Using Whole-Genome Sequencing To Investigate an Outbreak Originating from a Contaminated Domestic Water Supply. Journal of Clinical Microbiology 2015, 53, 1144–1148. [CrossRef]
- Tran, Q.T.L.; Phan, P.H.; Bui, L.N.H.; Bui, H.T.V.; Hoang, N.T.B.; Tran, D.M.; Trinh, T.T. Child Melioidosis Deaths Caused by Burkholderia pseudomallei-Contaminated Borehole Water, Vietnam, 2019. Emerg Infect Dis 2022, 28, 1689–1693. [CrossRef]
- Janssen-Groesbeek, K.; Elliman, J.; Rush, C.; Warner, J. Rainfall-Driven Mobilisation of Clinically Relevant Burkholderia pseudomallei in a Groundwater-Connected Urban Creek, Northern Australia. Pathogens 2026, 15, 276. [CrossRef]
- Liu, X.; Pang, L.; Sim, S.H.; Goh, K.T.; Ravikumar, S.; Win, M.S.; Tan, G.; Cook, A.R.; Fisher, D.; Chai, L.Y.A. Association of Melioidosis Incidence with Rainfall and Humidity, Singapore, 2003–2012. Emerging Infectious Diseases 2015, 21, 159–162. [CrossRef]
- Currie, B.J.; Ward, L.; Cheng, A.C. The Epidemiology and Clinical Spectrum of Melioidosis: 540 Cases from the 20 Year Darwin Prospective Study. PLoS Neglected Tropical Diseases 2010, 4, e900. [CrossRef]
- Chantratita, N.; Phunpang, R.; Yarasai, A.; Dulsuk, A.; Yimthin, T.; Onofrey, L.A.; Coston, T.D.; Thiansukhon, E.; Chaisuksant, S.; Tanwisaid, K.; et al. Characteristics and One Year Outcomes of Melioidosis Patients in Northeastern Thailand: A Prospective, Multicenter Cohort Study. Lancet Reg Health Southeast Asia 2023, 9. [CrossRef]
- Currie, B.J.; Mayo, M.; Ward, L.M.; Kaestli, M.; Meumann, E.M.; Webb, J.R.; Woerle, C.; Baird, R.W.; Price, R.N.; Marshall, C.S.; et al. The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation. The Lancet Infectious Diseases 2021, 21, 1737–1746. [CrossRef]
- Hill, A.A.; Mayo, M.; Kaestli, M.; Price, E.P.; Richardson, L.J.; Godoy, D.; Spratt, B.G.; Currie, B.J. Melioidosis as a consequence of sporting activity. Am J Trop Med Hyg 2013, 89, 365–366. [CrossRef]
- Kaestli, M.; Harrington, G.; Mayo, M.; Chatfield, M.D.; Harrington, I.; Hill, A.; Munksgaard, N.; Gibb, K.; Currie, B.J. What Drives the Occurrence of the Melioidosis Bacterium Burkholderia pseudomallei in Domestic Gardens? PLOS Neglected Tropical Diseases 2015, 9, e0003635. [CrossRef]
- Available online: https://www.socscistatistics.com/tests/chisquare2/default2.aspx (accessed on 21/11/2025).
- Australian Bureau of Statistics. 50 years of capital city population change. Available online: https://www.abs.gov.au/articles/50-years-capital-city-population-change (accessed on 10/05/2026).
- Australian Bureau of Meteorology. DC02D_Data_014015_9999999910968288 (1989-2024). 2026.
- R Foundation for Statistical Computing, 2026.
- Therneau, T.M. survival: Survival Analysis, Comprehensive R Archive Network (CRAN): 2024.
- Wood, S.N. mgcv: Mixed GAM Computation Vehicle with Automatic Smoothness Estimation, Comprehensive R Archive Network (CRAN): 2011.
- Hartig, F. DHARMa: Residual Diagnostics for Hierarchical (Multi-Level / Mixed) Regression Models, Comprehensive R Archive Network (CRAN): 2024.
- Howes, M.; Currie, B.J. Melioidosis and activation from latency: the “time bomb” has not occurred. The American journal of tropical medicine and hygiene 2024, 111, 156.
- Norman, F.F.; Blair, B.M.; Chamorro-Tojeiro, S.; González-Sanz, M.; Chen, L.H. The Evolving Global Epidemiology of Human Melioidosis: A Narrative Review. Pathogens 2024, 13, 926.
- Singh, H.; Currie, B.J.; Woerle, C.; Meumann, E.M. Epidemiology, Clinical Features, and Outcomes of Chronic Melioidosis in the Top End of Australia's Northern Territory, 1989–2023. Open Forum Infectious Diseases 2026, 13. [CrossRef]
- Singh, H.; Currie, B.; C, W.; Meumann, E. Epidemiology, clinical features and outcomes of chronic melioidosis in the Top End of Australia's Northern Territory, 1989-2023. Open forum infectious diseases 2026.
- Wu, W.-G.; Shum, M.H.-H.; Wong, I.T.-F.; Lu, K.K.; Lee, L.-K.; Leung, J.S.-L.; Lao, H.-Y.; Lee, A.W.-T.; Hau, P.-T.; Chan, C.T.-M. Probable airborne transmission of Burkholderia pseudomallei causing an urban outbreak of melioidosis during typhoon season in Hong Kong, China. Emerging Microbes & Infections 2023, 12, 2204155.
- Chen, P.-S.; Chen, Y.-S.; Lin, H.-H.; Liu, P.-J.; Ni, W.-F.; Hsueh, P.-T.; Liang, S.-H.; Chen, C.; Chen, Y.-L. Airborne Transmission of Melioidosis to Humans from Environmental Aerosols Contaminated with B. pseudomallei. PLOS Neglected Tropical Diseases 2015, 9, e0003834. [CrossRef]
- Fertitta, L.; Monsel, G.; Torresi, J.; Caumes, E. Cutaneous melioidosis: a review of the literature. International Journal of Dermatology 2019, 58, 221–227. [CrossRef]
- Gibney, B., Katherine; Cheng, C., Allen; Currie, J., Bart. Cutaneous Melioidosis in the Tropical Top End of Australia: A Prospective Study and Review of the Literature. Clinical Infectious Diseases 2008, 47, 603–609. [CrossRef]
- Mu, J.-J.; Cheng, P.-Y.; Chen, Y.-S.; Chen, P.-S.; Chen, Y.-L. The occurrence of melioidosis is related to different climatic conditions in distinct topographical areas of Taiwan. Epidemiology and Infection 2014, 142, 415–423. [CrossRef]
- Kaestli, M.; Grist, E.P.M.; Ward, L.; Hill, A.; Mayo, M.; Currie, B.J. The association of melioidosis with climatic factors in Darwin, Australia: A 23-year time-series analysis. Journal of Infection 2016, 72, 687–697. [CrossRef]
- Birnie, E.; Biemond, J.J.; Wiersinga, W.J. Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change. Current Opinion in Infectious Diseases 2022, 35, 196–204. [CrossRef]
- Chien, J.M.-F.; Saffari, S.E.; Tan, A.-L.; Tan, T.-T. Factors affecting clinical outcomes in the management of melioidosis in Singapore: a 16-year case series. BMC Infectious Diseases 2018, 18. [CrossRef]
- Thomas, A.; Forbes-Faulkner, J.; Parker, M. Isolation of Pseudomonas pseudomallei from layer layers at defined depths. American Journal of Epidemiology 1979, 110, 515–521. [CrossRef]
- Kaestli, M.; Schmid, M.; Mayo, M.; Rothballer, M.; Harrington, G.; Richardson, L.; Hill, A.; Hill, J.; Tuanyok, A.; Keim, P.; et al. Out of the ground: aerial and exotic habitats of the melioidosis bacterium Burkholderia pseudomallei in grasses in Australia. Environmental Microbiology 2012, 14, 2058–2070. [CrossRef]
- Williams, R. Australia's wet-dry tropics: identifying. The impact of climate change on ecosystems and species: terrestrial ecosystems 1995, 2, 39.
- Tothill, J.C.; Mott, J.J. Ecology and management of the world's savannas. 1985.
- Tai, Y.-L.; Weng, S.-L.; Li, S.-T.; Huang, Y.-N.; Chi, H.; Chiu, N.-C.; Lin, C.-Y. Unprecedented Surge of Melioidosis after Typhoon Events in Taiwan 2024. The American Journal of Tropical Medicine and Hygiene 2025, 113, 1341–1344. [CrossRef]
- Parameswaran, U.; Baird, R.W.; Ward, L.M.; Currie, B.J. Melioidosis at Royal Darwin Hospital in the big 2009–2010 wet season: comparison with the preceding 20 years. Medical Journal of Australia 2012, 196, 345–348. [CrossRef]
- Birnie, E.; Virk, H.S.; Savelkoel, J.; Spijker, R.; Bertherat, E.; Dance, D.A.B.; Limmathurotsakul, D.; Devleesschauwer, B.; Haagsma, J.A.; Wiersinga, W.J. Global burden of melioidosis in 2015: a systematic review and data synthesis. The Lancet Infectious Diseases 2019, 19, 892–902. [CrossRef]
- Limmathurotsakul, D.; Golding, N.; Dance, D.A.B.; Messina, J.P.; Pigott, D.M.; Moyes, C.L.; Rolim, D.B.; Bertherat, E.; Day, N.P.J.; Peacock, S.J.; et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature Microbiology 2016, 1, 15008. [CrossRef]
- Chiu, K.H.-Y.; Li, X.; Wong, S.-C.; Chen, J.H.-K.; Tsang, A.K.-L.; Chan, B.W.-K.; Poon, R.W.-S.; Yip, C.C.-Y.; Leung, S.S.-M.; So, S.Y.-C.; et al. Outbreak of melioidosis in a highly urbanized area. Emerging Microbes & Infections 2025, 14. [CrossRef]
- Rachlin, A.; Mayo, M.; Webb, J.R.; Kleinecke, M.; Rigas, V.; Harrington, G.; Currie, B.J.; Kaestli, M. Whole-genome sequencing of Burkholderia pseudomallei from an urban melioidosis hot spot reveals a fine-scale population structure and localised spatial clustering in the environment. Scientific Reports 2020, 10. [CrossRef]
- Smith, S.; Horne, P.; Rubenach, S.; Gair, R.; Stewart, J.; Fairhead, L.; Hanson, J. Increased Incidence of Melioidosis in Far North Queensland, Queensland, Australia, 1998–2019. Emerging Infectious Diseases 2021, 27, 3119–3123. [CrossRef]
- Baker, A.; Tahani, D.; Gardiner, C.; Bristow, K.L.; Greenhill, A.R.; Warner, J. Groundwater Seeps Facilitate Exposure to Burkholderia pseudomallei. Applied and Environmental Microbiology 2011, 77, 7243–7246. [CrossRef]
- Limmathurotsakul, D.; Dance, D.A.B.; Wuthiekanun, V.; Kaestli, M.; Mayo, M.; Warner, J.; Wagner, D.M.; Tuanyok, A.; Wertheim, H.; Yoke Cheng, T.; et al. Systematic Review and Consensus Guidelines for Environmental Sampling of Burkholderia pseudomallei. PLOS Neglected Tropical Diseases 2013, 7, e2105. [CrossRef]
- Smith, S.; Marquardt, T.; Jennison, A.V.; D'Addona, A.; Stewart, J.; Yarwood, T.; Ho, J.; Binotto, E.; Harris, J.; Fahmy, M.; et al. Clinical Manifestations and Genomic Evaluation of Melioidosis Outbreak among Children after Sporting Event, Australia. Emerg Infect Dis 2023, 29, 2218–2228. [CrossRef]
- Limmathurotsakul, D.; Kanoksil, M.; Wuthiekanun, V.; Kitphati, R.; Destavola, B.; Day, N.P.J.; Peacock, S.J. Activities of Daily Living Associated with Acquisition of Melioidosis in Northeast Thailand: A Matched Case-Control Study. PLoS Neglected Tropical Diseases 2013, 7, e2072. [CrossRef]
- Mohapatra, P.R.; Mishra, B. Prevention of melioidosis. Journal of Family Medicine and Primary Care 2022, 11.
- Currie, B.J.; Meumann, E.M. Melioidosis in Asia-Pacific Nations: Expanding Boundaries but Unknowns remains. Respirology 2025, 1–3. [CrossRef]
- Inglis, T.J.J.; Sousa, A.Q. The public health implications of melioidosis. Brazilian Journal of Infectious Diseases 2009, 13, 59–66. [CrossRef]
- Cousins, S. The neglect of melioidosis. The Lancet 2025, 406, 1550–1551. [CrossRef]

| Dry Season | Wet Season | Total | p-value | |
| All Admissions | 325 | 1195 | 1520 | |
| First Admissions | 283 (20% of all first admissions) * |
1156 (80% of all first admissions) |
1439 |
|
| Second Admissions | 43 | 39 | ||
| Demographics** | N=283 | N=1156 | N=1439 | |
| Female | 108 (38%) | 441 (38%) | 616 | |
| Male | 175 (62%) | 715 (62%) | 823 | |
| Age Range*** | 9 m – 91 y | 7 m – 97 y | 7 m – 97 y | |
| First Nations | 132 (47%) | 634 (55%) | 766 | 0.0132 |
| Region | ||||
| Darwin urban and rural | 136 (48%) | 652 (56%) | 788 | |
| Darwin regional | 50 (18%) | 134 (12%) | 184 | |
| NT Remote | 95 (34%) | 358 (31%) | 453 | |
| Other | 2 (1%) | 12 (1%) | 14 | |
| First Admission Diagnosis* | ||||
| Acute | 203 (73%) | 1077 (93%) | 1280 | <0.01 |
| Chronic | 58 (20%) | 71 (6%) | 129 | |
| Activation from latency | 21(7%) | 8 (<1%) | 29 | |
| Subsequent Admission Diagnosis | N=43 | N=39 | ||
| Relapse | 39 (91%) | 16 (41%) | 55 | <0.01 |
| New infection | 4 (9%) | 23 (59%) | 27 |
| Dry Season | Wet Season | p-value* | |||
| Total Case, N = 1280 | 203 | 16% | 1077 | 84% | |
| Risk Factors | |||||
| Diabetes | 83 | 41% | 523 | 49% | 0.045 |
| Hazardous Alcohol Use | 79 | 39% | 437 | 41% | 0.658 |
| Chronic Kidney Disease | 17 | 8% | 140 | 13% | 0.065 |
| Immunosuppression | 18 | 9% | 106 | 10% | 0.667 |
| No risk factors | 46 | 23% | 151 | 14% | 0.002 |
| Occupational exposure | 31 | 15% | 160 | 15% | 0.880 |
| Recreational exposure | 172 | 85% | 859 | 80% | 0.101 |
| Documented specific potential exposure event | 46 | 23% | |||
| Clinical Presentation | |||||
| Pneumonia | 61 | 30% | 627 | 58% | <0.001 |
| Cutaneous melioidosis | 44 | 22% | 90 | 8% | <0.001 |
| Genitourinary melioidosis | 35 | 17% | 132 | 12% | 0.053 |
| Bacteremia with no evident focus | 20 | 10% | 122 | 11% | 0.539 |
| Septic arthritis | 13 | 6% | 20 | 2% | <0.001 |
| Soft tissue infection | 10 | 5% | 38 | 4% | 0.336 |
| Neurological melioidosis | 7 | 3% | 16 | 1% | 0.054 |
| Osteomyelitis | 6 | 3% | 8 | 1% | 0.005 |
| Other | 7 | 3% | 24 | 2% | N/A |
| Clinical Outcomes | |||||
| Bacteraemia | 99 | 49% | 657 | 61% | 0.041 |
| Septic shock | 38 | 19% | 243 | 23% | 0.225 |
| Required intensive care | 50 | 25% | 270 | 25% | 0.895 |
| Ventilated | 27 | 13% | 171 | 16% | 0.352 |
| Died initial illness | 16 | 8% | 122 | 11% | 0.010 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).